A new OPIATE (Optimizing Positive Ibuprofen and Acetaminophen Treatment Expectations) model: A brief comment on "Concurrent and lagged associations of prescription opioid use with pain and negative affect in the daily lives of chronic pain patients" (Carpenter, Lane, Bruehl, & Trull, 2019).


Journal

Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553

Informations de publication

Date de publication:
10 2019
Historique:
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 10 3 2020
Statut: ppublish

Résumé

This commentary expands upon the clinical implications arising from the Carpenter et al. (2019) negative reinforcement model of opioid use. A new model called OPIATE-which stands for Optimizing Positive Ibuprofen and Acetaminophen Treatment Expectations-is introduced. This commentary highlights possible strategies for reducing the supply and demand of opioids through enhancing expectations for alternative pain medications. This commentary features an integration of concepts from social psychology, cognitive psychology, and consumer psychology with empirical findings from observational studies and randomized trials of opioid and nonopioid medications. Four behavioral strategies are offered for potential enhancing expectations for ibuprofen and acetaminophen. These strategies are (a) altering defaults in electronic medical record systems; (b) highlighting appropriate descriptive social norms to patients; (c) improving the quality of interactions during discharges between patients and their physicians, nurses, and pharmacists; and (d) priming patients to have positive expectations regarding ibuprofen and acetaminophen involving careful selection of language to describe these medications. Instead of creating alternative pharmaceuticals, efforts to prevent opioid misuse may be more fruitful by focusing on behavioral change of prescribers and patients because viable medication options-namely ibuprofen and acetaminophen-already exist. Psychologists have an opportunity to play a leading role in evaluating behavioral strategies for increasing expectations for and use of nonopioid pain medications. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 31556665
pii: 2019-57426-005
doi: 10.1037/ccp0000436
doi:

Substances chimiques

Analgesics, Opioid 0
Opiate Alkaloids 0
Acetaminophen 362O9ITL9D
Ibuprofen WK2XYI10QM

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

887-892

Commentaires et corrections

Type : CommentOn

Auteurs

Jack Stevens (J)

Center for Biobehavioral Health, Nationwide Children's Hospital.

Tarun Bhalla (T)

Department of Anesthesia and Pain Medicine, Akron Children's Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH